Results 11 to 20 of about 11,868,981 (258)

TGFBR3 (transforming growth factor, beta receptor III) [PDF]

open access: yesAtlas of Genetics and Cytogenetics in Oncology and Haematology, 2012
Review on TGFBR3 (transforming growth factor, beta receptor III), with data on DNA, on the protein encoded, and where the gene is implicated.
Gatza, CE, Rawson, D, Blobe, GC
openaire   +4 more sources

Intracellular trafficking of transforming growth factor β receptors [PDF]

open access: yesActa Biochimica et Biophysica Sinica, 2018
Transforming growth factor β (TGFβ) family members signal via heterotetrameric complexes of type I (TβRI) and type II (TβRII) dual specificity kinase receptors. The availability of the receptors on the cell surface is controlled by several mechanisms.
Ihor, Yakymovych   +2 more
openaire   +3 more sources

TGFBR3 (transforming growth factor, beta receptor III) [PDF]

open access: yesAtlas of Genetics and Cytogenetics in Oncology and Haematology, 2011
Review on TGFBR3 (transforming growth factor, beta receptor III), with data on DNA, on the protein encoded, and where the gene is implicated.
Gatza, CE, Blobe, GC
openaire   +4 more sources

GROWTH FACTOR AND ADIPOKINE RECEPTORS IN PATHOGENESIS AND PROGNOSIS OF ENDOMETRIAL CANCER IN PATIENTS WITH METABOLIC SYNDROME

open access: yesСибирский онкологический журнал, 2016
The role of growth factor receptors (insulin-like growth factor and transforming growth factor-beta) and adipokine receptors (leptin and adiponectin) in pathogenesis of endometrial cancer under conditions of metabolic syndrome is discussed ...
N. V. Yunusova   +4 more
doaj   +1 more source

Immunological studies of chronic ocular toxoplasmosis : up-regulation of major histocompatibility complex class I and transforming growth factor beta and a protective role for interleukin-6 [PDF]

open access: yes, 2001
A murine model was used to characterize the local immune and inflammatory response during ocular toxoplasmosis. Major histocompatibility complex (MHC) class I, normally expressed at low levels in immune-privileged sites such as the eye, was up-regulated ...
Ferguson, D. J. P.   +17 more
core   +4 more sources

Expression of transforming growth factor‐beta isoforms and their receptors in chronic tendinosis [PDF]

open access: yesJournal of Anatomy, 2001
Chronic tendon lesions are degenerative conditions and may represent a failure to repair or remodel the extracellular matrix after repeated micro‐injury. Since TGF‐β is strongly associated with tissue repair, we investigated the expression of TGF‐β isoforms (β1, β2 and β3) and their 2 signalling receptors (TGF‐βRI and TGF‐βRII) in normal and ...
Fenwick, S. A.   +5 more
openaire   +4 more sources

Bacterial meningitis: the role of transforming growth factor-Beta in innate immunity and secondary brain damage [PDF]

open access: yes, 2007
Project 6 of the NCCR 'Neural Plasticity and Repair' focuses on mechanisms of immunity and tissue damage in autoimmune and infectious diseases of the central nervous system (CNS).
Malipiero, U   +11 more
core   +1 more source

Activation of transforming growth factor beta by malaria parasite-derived metalloproteinases and a thrombospondin-like molecule [PDF]

open access: yes, 2003
Much of the pathology of malaria is mediated by inflammatory cytokines (such as interleukin 12, interferon gamma, and tumor necrosis factor alpha), which are part of the immune response that kills the parasite.
Riley, Eleanor M   +14 more
core   +1 more source

Transforming growth factor-beta family annotation.

open access: yes, 2023
Transforming growth factor-beta family annotation.
Antonio Carlos A. Meireles-Filho (15213879)   +82 more
core   +1 more source

Epigenetic downregulation of human disabled homolog 2 switches TGF-beta from a tumor suppressor to a tumor promoter [PDF]

open access: yes, 2010
The cytokine TGF-beta acts as a tumor suppressor in normal epithelial cells and during the early stages of tumorigenesis. During malignant progression, cancer cells can switch their response to TGF-beta and use this cytokine as a potent oncogenic factor;
Hiller, L   +130 more
core   +1 more source

Home - About - Disclaimer - Privacy